Corinda Taylor

Cytotoxic Chromosomal Targeting by CRISPR/Cas Systems Can Reshape Bacterial Genomes and Expel or Remodel Pathogenicity Islands

Reuben B. Vercoe, James T. Chang, Ron L. Dy et al. · PLoS Genetics · 2013 · 349 citations · Full text

Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species

April Pawluk, Raymond H.J. Staals, Corinda Taylor et al. · Nature Microbiology · 2016 · 321 citations

Crispr-cas Systems, Molecular Biology, Genetic Engineering +8

Quorum Sensing Controls Adaptive Immunity through the Regulation of Multiple CRISPR-Cas Systems

Adrian G Patterson, Simon A. Jackson, Corinda Taylor et al. · Molecular Cell · 2016 · 236 citations · Full text

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin

Gerald W. Tannock, Karen Munro, Corinda Taylor et al. · Microbiology · 2010 · 215 citations

Dysbiosis, Clostridium Difficile-infected Patients, Antibiotic Resistance +17

Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer

Corinna Richter, Ron L. Dy, Rebecca E. McKenzie et al. · Nucleic Acids Research · 2014 · 188 citations · Full text

Engineering, Microbial Pathogens, Genetics +20